PubRank

Michael E Ming

Author PubWeight™ 36.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol 2004 3.43
2 An atypical melanocytic lesion without genomic abnormalities shows locoregional metastasis. J Cutan Pathol 2012 2.31
3 Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol 2007 2.06
4 Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol 2004 1.90
5 Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus. Arch Dermatol 2002 1.90
6 Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 2005 1.84
7 Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med 2006 1.65
8 Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions? Am J Clin Pathol 2003 1.50
9 Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? Cancer 2010 1.34
10 Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients. Health Psychol 2010 1.22
11 Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis. Hum Pathol 2008 1.19
12 Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma. J Clin Oncol 2005 1.11
13 Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma. Cancer 2006 1.08
14 Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients. Ann Surg Oncol 2007 1.02
15 Predictors of regional nodal disease in patients with thin melanomas. Ann Surg Oncol 2006 1.00
16 Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors. Cancer Epidemiol Biomarkers Prev 2013 0.94
17 Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi. Am J Dermatopathol 2004 0.92
18 Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma. Clin Cancer Res 2011 0.90
19 Melanoma chemoprevention. J Am Acad Dermatol 2006 0.88
20 Characteristics associated with early and late melanoma metastases. Cancer 2010 0.88
21 Effect of personalization and candy incentive on response rates for a mailed survey of dermatologists. J Invest Dermatol 2011 0.87
22 Survival is not the only valuable end point in melanoma screening. J Invest Dermatol 2012 0.83
23 Association between the anatomic distribution of melanoma and sex. J Am Acad Dermatol 2007 0.82
24 Investment in body image among patients diagnosed with or at risk for malignant melanoma. Body Image 2005 0.82
25 Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions. Arch Dermatol 2003 0.80
26 Eruptive disseminated Spitz nevi. J Am Acad Dermatol 2007 0.80
27 Mail surveys can achieve high response rates in a dermatology patient population. J Invest Dermatol 2004 0.78
28 The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. Arch Dermatol 2010 0.78
29 Psychosocial factors related to the correspondence of recipient and provider perceptions of social support among patients diagnosed with or at risk for malignant melanoma. J Health Psychol 2003 0.78
30 Skin surveillance intentions among family members of patients with melanoma. BMC Public Health 2011 0.78
31 Characteristics of dermatologists who read dermatopathology slides. J Cutan Pathol 2007 0.75
32 A rapidly growing nodule and dome-shaped yellow papules on the face. Arch Dermatol 2005 0.75
33 Merkel cell carcinoma. Curr Treat Options Oncol 2004 0.75